From February 6, 2024 to March 31, 2024, the company has repurchased 99,900 shares, representing 0.02% for CNY 2.94 million. With this, the company has completed the repurchase of 99,900 shares, representing 0.02% for CNY 2.94 million under the buyback announced on February 7, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
36.15 CNY | +1.83% | +1.95% | +3.29% |
07/05 | China Shares Rise as Property Market Gets Relief; BrightGene Jumps 7% | MT |
07/05 | BrightGene to Sell 500 Million Yuan Shares to Actual Controller; Shares Up 3% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.29% | 210.77Cr | |
+48.79% | 78TCr | |
+41.34% | 64TCr | |
+19.43% | 33TCr | |
+7.18% | 29TCr | |
+17.42% | 25TCr | |
-0.04% | 22TCr | |
+11.41% | 22TCr | |
+4.53% | 16TCr | |
-3.92% | 16TCr |
- Stock Market
- Equities
- 688166 Stock
- News BrightGene Bio-Medical Technology Co., Ltd.
- Tranche Update on BrightGene Bio-Medical Technology Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.